Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Posts 1 Percent Dip in Fiscal Q1 Revenues

NEW YORK (GenomeWeb News) – Accelrys yesterday reported a 1 percent decline in revenues for its first fiscal quarter as its net income improved over the year-ago period.

Accelrys said that revenues for the three months ended June 30 decreased to $20.1 million from $20.3 million in the prior-year period. The company attributed the decrease to a drop in maintenance revenue of around $400,000, which was partially offset by an increase in software revenue of around $300,000.

Net income increased to $744,000 from $86,000 in the comparable period of 2008.

Product development expenses decreased 9 percent to $3.9 million from $4.3 million in the year-ago period, while sales and marketing expenses remained flat at $8.1 million.

General and administrative expenses increased 6 percent to $3.7 million from $3.5 million for the three months ended June 30, 2008.

The company had cash, cash equivalents, marketable securities, and restricted cash of $83.7 million as of June 30.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.